Hydrazine Monohydrate

Hazard statements (CLP)

H301, H314, H317, H341, H350, H370, H372, H410

Code

Statements

H301

Toxic if swallowed

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H301 Toxic if swallowed. H314 Causes severe skin burns and eye damage. H317 May cause an allergic skin reaction. H341 Suspected of causing genetic defects. H350 May cause cancer. H370 Causes damage to organs (Liver, Kidney, Central nervous system). H372 Causes damage to organs (Liver, Gastrointestinal tract, Nervous system, Kidney) through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects.

Prevention

P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.

Response

P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor. P391 Collect spillage.

Additional information

Restricted to professional users

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 3 H301: Toxic if swallowed. Skin corrosion, Sub-category 1B H314: Causes severe skin burns and eye damage. Serious eye damage, Category 1 H318: Causes serious eye damage. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Germ cell mutagenicity, Category 2 H341: Suspected of causing genetic defects. Carcinogenicity, Category 1B H350: May cause cancer. Specific target organ toxicity - single expo- H370: Causes damage to organs. sure, Category 1, Liver, Kidney, Central nerv- ous system Specific target organ toxicity - repeated expo- H372: Causes damage to organs through prolonged or sure, Category 1, Liver, Gastrointestinal tract, repeated exposure. Nervous system, Kidney Short-term (acute) aquatic hazard, Category 1 H400: Very toxic to aquatic life. Long-term (chronic) aquatic hazard, Category H410: Very toxic to aquatic life with long lasting effects. 1